Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Fact Sheet  (AUBD)



Important: A Big Prediction of Our Senior Analyst


Here is the latest financial fact sheet of AUROBINDO PHARMA. For more details, see the AUROBINDO PHARMA quarterly results and AUROBINDO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

AUROBINDO PHARMA Price History

Price Rs 1,042.5
Mkt Cap Rs m 610,812
Vol '000 146.4
P/E X 26.2
P/CF X 19.3
EPS (TTM) Rs 39.7
1 Day % 0.9
No. of shares m 585.94
1 Week % 1.0
1 Month % 21.4
1 Year % 122.3
52 week H/L Rs 1,059.3/397.3
As on Dec 4, 2023 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

AUROBINDO PHARMA Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
AUROBINDO PHARMA EQUITY SHARE DATA
High Rs8308381,0231,064715 
Low Rs527281333584397 
Sales per share (Unadj.) Rs333.9394.2422.8400.3424.2 
Earnings per share (Unadj.) Rs40.348.591.045.232.9 
Diluted earnings per shareRs40.348.591.045.232.9 
Cash flow per share (Unadj.) Rs51.765.0109.064.454.1 
Dividends per share (Unadj.) Rs2.503.004.009.003.00 
Adj. dividends per shareRs2.503.004.009.003.00 
Avg Dividend yield %0.40.50.61.10.5 
Book value per share (Unadj.) Rs237.1287.1374.3419.4458.1 
Adj. book value per shareRs237.1287.1374.3419.4458.1 
Shares outstanding (eoy) m585.89585.94585.94585.94585.94 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x2.01.41.62.11.3 
Avg P/E ratio x16.811.57.518.216.9 
P/CF ratio (eoy) x13.18.66.212.810.3 
Price / Book Value ratio x2.91.91.82.01.2 
Dividend payout %6.26.24.419.99.1 
Avg Mkt Cap Rs m397,541327,877397,398482,799325,753 
No. of employees `000NANANANANA 
Total wages/salary Rs m25,84932,19235,35034,50935,223 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
AUROBINDO PHARMA INCOME DATA
Net Sales Rs m195,636230,985247,746234,555248,554 
Other income Rs m1,5531,9193,8093,2262,906 
Total revenues Rs m197,189232,904251,555237,781251,460 
Gross profit Rs m38,63948,23080,92642,25337,070 
Depreciation Rs m6,6809,66710,55411,26512,446 
Interest Rs m2,6263,0517454861,405 
Profit before tax Rs m30,88737,43073,43633,72726,125 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m7,2698,99420,0987,2566,849 
Profit after tax Rs m23,61828,43753,33826,47119,277 
Gross profit margin %19.820.932.718.014.9 
Effective tax rate %23.524.027.421.526.2 
Net profit margin %12.112.321.511.37.8 
AUROBINDO PHARMA BALANCE SHEET DATA
Current assets Rs m153,323164,125197,399180,436214,599 
Current liabilities Rs m120,206113,846106,65181,560114,938 
Net working cap to sales %16.921.836.642.240.1 
Current ratio x1.31.41.92.21.9 
Inventory Days Days1515192521 
Debtors Days Days6468526266 
Net fixed assets Rs m109,388123,520135,778155,104176,668 
Share capital Rs m586586586586586 
"Free" reserves Rs m138,321167,661218,713245,174267,813 
Net worth Rs m138,907168,247219,299245,760268,399 
Long term debt Rs m1,80001,6852,4926,190 
Total assets Rs m262,711287,645334,013336,331392,125 
Interest coverage x12.813.399.670.319.6 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.80.70.70.6 
Return on assets %10.010.916.28.05.3 
Return on equity %17.016.924.310.87.2 
Return on capital %23.824.133.613.810.0 
Exports to sales %49.646.453.831.133.7 
Imports to sales %18.815.116.411.915.3 
Exports (fob) Rs m97,091107,126133,24872,86283,703 
Imports (cif) Rs m36,74134,90240,61527,96538,060 
Fx inflow Rs m97,316107,445133,44777,24585,483 
Fx outflow Rs m40,58938,99144,94631,52441,447 
Net fx Rs m56,72768,45488,50145,72144,036 
AUROBINDO PHARMA CASH FLOW
From Operations Rs m 16,510 43,813 33,291 50,165 23,868 
From Investments Rs m -29,026 -15,676 5,987 -32,116 -39,778 
From Financial Activity Rs m 19,191 -19,472 -13,649 -29,693 18,144 
Net Cashflow Rs m 6,656 8,712 25,831 -11,674 2,298 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 51.8%
Institution 40.7%
Non-Institution 7.4%
Total 100.0%
Free Float 48.2%
Pledged promoter holdings 19.6%
Shareholding as on Sep 2023
 

Company Information

Regd Off Plot No. 2, Maitrivihar, Ameerpet, Hyderabad - 500038
E-mail info@aurobindo.com Web www.aurobindo.com
Tel 040-23736370 / 23747340 Fax 040-23741080 / 23746833
Sector PHARMACEUTICALS Group Aurobindo
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor S. R. Batliboi & Assoc.
CHM: K Ragunathan COMP SEC: B Adi Reddy YEAR OF INC: 1986 BSE CODE: 524804 FV (Rs): 1 DIV YIELD (%): 0.3

Read: AUROBINDO PHARMA 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    PIRAMAL ENTERPRISES    LUPIN    

Compare AUROBINDO PHARMA With:   DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    PIRAMAL ENTERPRISES    LUPIN    




Today's Market

L&T Finance Completes Subsidiaries Merger | Why Adani Ports Share Price is Rising | Top Buzzing Stocks Today L&T Finance Completes Subsidiaries Merger | Why Adani Ports Share Price is Rising | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets continued the momentum as the session progressed and ended the day on firm footing.